Cell Counting Market 2021 Key Players, SWOT Analysis, Key Indicators, Forecast and COVID-19 Impact Analysis 2025

SDKI Inc. published a new report on the Cell Counting Market-Global Forecast 2023. This study includes the statistical and analytical approaches needed to grow the cell counting market. The key industry insights provided in the report provide readers with better ideas about market overviews regarding existing market scenarios. In addition, the report contains a detailed discussion of current and future market trends related to market growth.

Report sample URL
https://www.sdki.jp/sample-request-110043

The cell counting market is estimated to reach US $ 12.32 billion by 2023 from US $ 8.84 billion in 2018 and is expected to grow at a CAGR of 6.8% during the forecast period. Increasing rates of illness and disability, the development of enhanced solutions and improved image analysis, and increased use of high-throughput flow cytometry and automated blood analyzers are some of the factors driving the growth of this market. is.

Market segment

The cell counting market is by product (equipment (spectrophotometer, cell counter, hemocytometer, flow cytometer, blood analyzer), consumables (reagents, assay kit, microplate)), by end user (pharmaceutical). , Hospitals, Research), by application, and by region. These segments are further subsegmented based on various factors and consist of some additional information about the market, such as the combined annual growth rate of each segment and subsegment, the market value and volume of the valuation period.

Based on the product, the consumables segment is expected to register the largest CAGR during the forecast period. This growth may be due to the use of various consumables in stem cell and cancer research. The expansion of applications in quality control procedures in various industries such as food and beverage, pharmaceutical and biotechnology product manufacturing, as well as in the areas of environmental monitoring and water treatment, has also contributed to the growth of the segment.

Report sample URL
https://www.sdki.jp/sample-request-110043

Based on the end user, the cell counting market is divided into research institutes, hospitals, clinical laboratories, pharmaceutical and biotechnology companies, and other end users. The hospital segment is expected to register a significant CAGR during the forecast period. This may be due to the adoption of cell counting devices for the diagnosis and treatment of some illnesses, and the continued consumption of consumables.

Area overview

North America had the largest share of the global cell counting market in 2018. Meanwhile, the Asia Pacific region shows a significant CAGR during the forecast period due to increased prevalence of chronic and infectious diseases, increased patient numbers, increased medical costs, and increased interest from key players in Asia Pacific countries. Is expected.

The market is further subdivided based on the region, and the market growth of each country is evaluated. These include North America (US and Canada); Europe (UK, Germany, France, Italy, Spain, Hungary, Belgium, Netherlands, Luxemburg, NORDIC, Poland, Turkey, Russia and other Europe); Asia Pacific (China, India). , Japan, South Korea, Indonesia, Malaysia, Australia, New Zealand, Other Asia Pacific); Latin America (Brazil, Mexico, Argentina, Other Latin America); and Middle East and Africa (Israel, GCC [Saudi Arabia, Arab Emirates, Bahrain, Kwat, Qatar, Oman], North Africa, South Africa, and other Middle East and Africa).

Details of the survey report
https://www.sdki.jp/reports/cell-counting-market/110043

The study includes a detailed competitive analysis of these major companies in the cell counting market, corporate profiles, recent developments, and key market strategies.

SDKI Inc. Company Profile

SDKI Inc.'s goal is market scenarios in various countries such as Japan, China, the United States, Canada, the United Kingdom, and Germany. Is to clarify. We also focus on providing reliable research insights to clients around the world, including growth indicators, challenges, trends and competitive environments, through a diverse network of research analysts and consultants. With SDKI gaining trust and a customer base in more than 30 countries, SDKI is even more focused on expanding its foothold in other pristine economies.

Contact Us

Hina Miyazu
15/F Cerulean Tower, 26-1 Sakuragaoka-cho
Tokyo, Shibuya-ku, Japan
+ 81345720790
sales@sdki.jp

This release was published on openPR.